<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <title>PromptGenix – BioAI Automation Platform</title>
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <style>
    * { box-sizing: border-box; }
    body {
      margin: 0;
      font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", sans-serif;
      color: #111827;
      background: #0b1020;
    }
    header {
      padding: 24px 8%;
      display: flex;
      justify-content: space-between;
      align-items: center;
      background: rgba(5, 10, 25, 0.9);
      position: sticky;
      top: 0;
      z-index: 10;
      backdrop-filter: blur(10px);
    }
    header h1 {
      margin: 0;
      font-size: 1.4rem;
      color: #e5e7eb;
    }
    header nav a {
      margin-left: 18px;
      text-decoration: none;
      font-size: 0.95rem;
      color: #9ca3af;
    }
    header nav a:hover {
      color: #fbbf24;
    }
    .hero {
      padding: 80px 8% 60px;
      display: grid;
      grid-template-columns: minmax(0, 1.4fr) minmax(0, 1fr);
      gap: 40px;
      align-items: center;
    }
    .hero-title {
      font-size: 2.6rem;
      line-height: 1.2;
      color: #f9fafb;
      margin-bottom: 16px;
    }
    .hero-subtitle {
      font-size: 1.05rem;
      color: #d1d5db;
      margin-bottom: 24px;
    }
    .badge {
      display: inline-flex;
      align-items: center;
      padding: 4px 10px;
      border-radius: 999px;
      font-size: 0.75rem;
      color: #fbbf24;
      background: rgba(251, 191, 36, 0.1);
      border: 1px solid rgba(251, 191, 36, 0.3);
      margin-bottom: 12px;
    }
    .hero-buttons a {
      display: inline-block;
      padding: 10px 18px;
      border-radius: 999px;
      font-size: 0.95rem;
      text-decoration: none;
      margin-right: 10px;
      margin-bottom: 10px;
    }
    .btn-primary {
      background: linear-gradient(135deg, #fbbf24, #ea580c);
      color: #111827;
      font-weight: 600;
    }
    .btn-secondary {
      border: 1px solid #4b5563;
      color: #e5e7eb;
    }
    .hero-card {
      background: radial-gradient(circle at top, #1f2937, #020617);
      border-radius: 24px;
      padding: 24px;
      border: 1px solid #374151;
      color: #e5e7eb;
    }
    .hero-card h3 {
      margin-top: 0;
      margin-bottom: 8px;
      font-size: 1.1rem;
    }
    .hero-card ul {
      padding-left: 18px;
      margin: 8px 0 0;
      font-size: 0.9rem;
      color: #d1d5db;
    }
    section {
      padding: 50px 8%;
    }
    section h2 {
      font-size: 1.6rem;
      margin: 0 0 18px;
      color: #f9fafb;
    }
    section p, section li {
      color: #d1d5db;
      font-size: 0.95rem;
    }
    .grid-2 {
      display: grid;
      grid-template-columns: repeat(2, minmax(0, 1fr));
      gap: 32px;
    }
    .card {
      background: #020617;
      border-radius: 18px;
      padding: 20px 22px;
      border: 1px solid #1f2937;
    }
    .card h3 {
      margin-top: 0;
      margin-bottom: 10px;
      font-size: 1.1rem;
      color: #f9fafb;
    }
    .pill-list {
      display: flex;
      flex-wrap: wrap;
      gap: 6px;
      margin-top: 10px;
    }
    .pill {
      padding: 4px 10px;
      border-radius: 999px;
      font-size: 0.8rem;
      border: 1px solid #4b5563;
      color: #e5e7eb;
    }
    .team {
      display: grid;
      grid-template-columns: repeat(2, minmax(0, 1fr));
      gap: 24px;
    }
    .team-member h3 {
      margin: 0 0 4px;
      font-size: 1.05rem;
      color: #fbbf24;
    }
    .team-member h4 {
      margin: 0 0 8px;
      font-size: 0.95rem;
      color: #e5e7eb;
      font-weight: 500;
    }
    footer {
      padding: 20px 8% 30px;
      border-top: 1px solid #1f2937;
      text-align: center;
      font-size: 0.8rem;
      color: #6b7280;
      background: #020617;
    }
    @media (max-width: 900px) {
      .hero {
        grid-template-columns: minmax(0, 1fr);
      }
      .grid-2, .team {
        grid-template-columns: minmax(0, 1fr);
      }
      header {
        flex-direction: column;
        align-items: flex-start;
        gap: 10px;
      }
    }
  </style>
</head>
<body>

<header>
  <h1>PromptGenix</h1>
  <nav>
    <a href="#problem">Problem</a>
    <a href="#solution">Platform</a>
    <a href="#usecases">Use Cases</a>
    <a href="#team">Team</a>
    <a href="#contact">Contact</a>
  </nav>
</header>

<section class="hero">
  <div>
    <div class="badge">Women & Minority-Owned BioAI Automation</div>
    <h2 class="hero-title">
      End-to-end RNA-Seq & Flow Cytometry analysis, automated and explained.
    </h2>
    <p class="hero-subtitle">
      PromptGenix turns raw FASTQ and FCS files into reproducible, publication-ready
      reports using automated pipelines and LLM-based scientific interpretation.
    </p>
    <div class="hero-buttons">
      <a href="#contact" class="btn-primary">Discuss a pilot</a>
      <a href="#solution" class="btn-secondary">See how it works</a>
    </div>
  </div>
  <div class="hero-card">
    <h3>What PromptGenix does</h3>
    <ul>
      <li>Automates RNA-Seq, scRNA-seq, and flow cytometry pipelines</li>
      <li>Runs COMPASS, GSEA/GSVA, and advanced statistics by default</li>
      <li>Generates clear English summaries of complex immune signatures</li>
      <li>Deploys securely on local Mac Studio or AWS cloud</li>
    </ul>
  </div>
</section>

<section id="problem">
  <h2>The Problem</h2>
  <div class="grid-2">
    <div>
      <p>
        Modern immunology and genomics labs collect terabytes of RNA-seq and flow cytometry data,
        but analysis still depends on fragmented tools, manual scripts, and a handful of experts.
        Turnaround time is measured in weeks, not hours, and every project feels like a one-off.
      </p>
    </div>
    <div class="card">
      <h3>Today's bottlenecks</h3>
      <ul>
        <li>Multiple disconnected tools (STAR, RSEM, FlowJo, COMPASS, GSEA)</li>
        <li>Custom scripts that are hard to reuse and harder to maintain</li>
        <li>Limited access to biostatistics & bioinformatics experts</li>
        <li>Scientific interpretation left to overworked PIs and analysts</li>
      </ul>
    </div>
  </div>
</section>

<section id="solution">
  <h2>The PromptGenix Platform</h2>
  <div class="grid-2">
    <div class="card">
      <h3>Automated pipelines</h3>
      <ul>
        <li>RNA-Seq: QC → alignment → quantification → DEG → GSEA/GSVA</li>
        <li>Flow cytometry: preprocessing, auto-gating, batch normalization</li>
        <li>COMPASS: automated polyfunctionality analysis for vaccines & trials</li>
        <li>scRNA-seq: Seurat / scanpy integration and cell-type reporting</li>
      </ul>
    </div>
    <div class="card">
      <h3>LLM-based interpretation</h3>
      <ul>
        <li>Plain-language summaries of pathways and immune signatures</li>
        <li>Contextualization with disease area and literature</li>
        <li>Exportable HTML/PDF reports ready for lab meetings or manuscripts</li>
        <li>Runs locally or on the cloud for secure environments</li>
      </ul>
    </div>
  </div>

  <div class="pill-list">
    <div class="pill">Python & R pipelines</div>
    <div class="pill">BioGPT & LangChain</div>
    <div class="pill">Hybrid local + AWS</div>
    <div class="pill">Reproducible analytics</div>
  </div>
</section>

<section id="usecases">
  <h2>Who We Serve</h2>
  <div class="grid-2">
    <div class="card">
      <h3>Translational research labs</h3>
      <ul>
        <li>Rapid iteration on vaccine and therapeutic studies</li>
        <li>Standardized analysis across cohorts and sites</li>
        <li>Automatic documentation for reproducible science</li>
      </ul>
    </div>
    <div class="card">
      <h3>Hospitals, Biotech & CROs</h3>
      <ul>
        <li>Scalable analysis for clinical trials and biomarker discovery</li>
        <li>Secure deployment with on-premise or VPC options</li>
        <li>Women- & minority-owned vendor for government contracts</li>
      </ul>
    </div>
  </div>
</section>

<section id="team">
  <h2>Team</h2>
  <div class="team">
    <div class="team-member">
      <h3>Yon Ji, Ph.D.</h3>
      <h4>CEO & Co-Founder</h4>
      <p>
        Molecular and cell biologist with 20+ years of experience across NIAID/NIH,
        Johns Hopkins, and NCI. Expertise in ChIP-seq, RNA-seq, CRISPR, stem cells,
        C. elegans and Xenopus models, and cancer biology. Leads strategy,
        partnerships, and operations for PromptGenix.
      </p>
    </div>
    <div class="team-member">
      <h3>Dohoon Kim, M.S.</h3>
      <h4>CTO & Co-Founder</h4>
      <p>
        Senior data scientist and computational biologist with 12+ years in infectious
        disease research at Walter Reed. Specializes in biostatistics, ML, RNA-seq and
        flow cytometry automation, COMPASS workflows, and LLM-powered
        bioinformatics agents in R and Python.
      </p>
    </div>
  </div>
</section>

<section id="sbir">
  <h2>SBIR Project Overview (For Reviewers)</h2>
  <div class="card" style="margin-bottom:16px;">
    <h3>Project Title</h3>
    <p>
      <strong>PromptGenix:</strong> An automated, LLM-assisted platform for RNA-Seq and flow cytometry
      analysis in translational immunology and infectious disease research.
    </p>
    <p style="font-size:0.9rem; color:#9ca3af;">
      Small Business: <strong>PromptGenix LLC</strong> &nbsp;|&nbsp;
      Proposed PI/Contact: <strong>Dohoon Kim, M.S.</strong> (CTO) &amp; <strong>Yon Ji, Ph.D.</strong> (CEO)
    </p>
  </div>

  <div class="grid-2">
    <div class="card">
      <h3>Unmet Need</h3>
      <ul>
        <li>RNA-Seq, scRNA-seq, and flow cytometry data are critical in vaccine and immunology studies, but analysis remains slow, manual, and fragmented across tools.</li>
        <li>Many labs lack in-house biostatistics/bioinformatics support, leading to long delays and inconsistent pipelines.</li>
        <li>Existing commercial tools focus on either NGS or cytometry, rarely integrating both with modern ML/LLM-based interpretation.</li>
      </ul>
    </div>
    <div class="card">
      <h3>Innovation & Aims (Phase I)</h3>
      <ul>
        <li><strong>Aim 1:</strong> Build a reproducible, containerized pipeline that automates RNA-Seq and flow cytometry analysis (QC → DEG/GSEA → COMPASS) from raw FASTQ/FCS files.</li>
        <li><strong>Aim 2:</strong> Integrate a domain-tuned LLM that produces clear, reviewer-friendly reports summarizing key immune signatures and pathways.</li>
        <li><strong>Aim 3:</strong> Validate the platform on publicly available immunology datasets and generate benchmarks vs. current manual workflows.</li>
      </ul>
    </div>
  </div>

  <div class="grid-2" style="margin-top:24px;">
    <div class="card">
      <h3>Approach & Milestones</h3>
      <ul>
        <li>Implement modular pipelines in Python/R (Snakemake/Nextflow-ready) for RNA-Seq and flow cytometry, containerized for secure deployment.</li>
        <li>Develop an LLM “analysis copilot” that links statistical outputs (DEG tables, COMPASS scores, pathways) to concise English summaries.</li>
        <li>Demonstrate feasibility with 2–3 use cases (e.g., vaccine trial, HIV or COVID-19 cohort) using public data.</li>
        <li>Deliverables: prototype web UI, reproducible code repository, and example Phase I report packets.</li>
      </ul>
    </div>
    <div class="card">
      <h3>Team & Environment</h3>
      <ul>
        <li><strong>Yon Ji, Ph.D. (CEO):</strong> 20+ years in molecular and cell biology (NIH/NIAID, NCI, Johns Hopkins); leads strategy and translational relevance.</li>
        <li><strong>Dohoon Kim, M.S. (CTO/PI):</strong> 10+ years as data scientist/biostatistician in infectious disease at Walter Reed; expert in RNA-Seq, flow cytometry, COMPASS, and ML.</li>
        <li>Infrastructure: secure local Mac Studio + cloud (AWS-ready) environment for development and testing.</li>
      </ul>
    </div>
  </div>

  <div class="card" style="margin-top:24px;">
    <h3>Phase I Outcomes & Next Steps</h3>
    <ul>
      <li>Phase I will produce a working prototype capable of turning raw FASTQ/FCS data into integrated, LLM-assisted reports suitable for lab meetings and manuscripts.</li>
      <li>Phase II will extend to multi-site clinical trials, add user management and audit trails, and integrate with hospital or CRO data environments.</li>
      <li>Commercialization strategy focuses on subscriptions for research labs, hospitals, and CROs, with emphasis on government and minority-owned contracts.</li>
    </ul>
    <p style="font-size:0.9rem; color:#9ca3af; margin-top:10px;">
      <strong>For SBIR reviewers:</strong> This page summarizes the proposed Phase I scope. A detailed work plan, budget, and regulatory/compliance discussion are provided in the full application.
    </p>
  </div>
</section>

  
<section id="contact">
  <h2>Contact</h2>
  <p>
    PromptGenix is currently preparing pilot collaborations with research labs,
    hospitals, and biotech partners. If you are interested in automating your
    RNA-Seq or flow cytometry workflows, we'd love to talk.
  </p>
  <p>
    <strong>Email (CEO)</strong>: jiy@nih.gov<br/>
    <strong>Email (CTO)</strong>: dk364@georgetown.edu &nbsp;/&nbsp; dohoon.kim1@icloud.com
  </p>
</section>

<footer>
  © <span id="year"></span> PromptGenix LLC. All rights reserved.
</footer>

<script>
  document.getElementById("year").textContent = new Date().getFullYear();
</script>

</body>
</html>
